← Back to Search

Group B1 for Osteoarthritis

N/A

Waitlist Available

Research Sponsored by Dr. Kevin Rod

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up the outcome will be measured over a period of 6 weeks.

Summary

To evaluate a new, low intensity ultrasound device in the treatment of chronic pain due to osteoarthritis in the knee. Enhancing CBD oil penetration into joints by sonophoresis.

Eligible Conditions

Osteoarthritis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ the outcome will be measured over a period of 6 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~the outcome will be measured over a period of 6 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and the outcome will be measured over a period of 6 weeks. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Pain Intensity Measure

Trial Design

4Treatment groups

Active Control

Placebo Group

Group I: Group B2Active Control1 Intervention

This group of patients will not receive high CBD oil to the affected joint.

Group II: Group B1Active Control1 Intervention

The first patient group will receive high CBD oil applied topically to the affected knee joint.

Group III: Group AActive Control1 Intervention

The first patient group will receive Low Intensity Ultrasound Therapy on the affected knee joint, using the CPI-LIPUS Device

Group IV: Group BPlacebo Group1 Intervention

Will be "treated" with an identical device whose ultrasound emitting capabilities has been nullified. This device appears to operate, including illumination of the operating light.

Do I qualify?Apply below to find out